Elizabeth Motunrayo Kolawole portrait
  • Research Assistant Professor, Pathology


  • The Diversity and Science Lecture Series (DASL) Invited. , Accepted, 2021.


  • McLeod JJA, Caslin HL, Spence AJ, Kolawole EM, Qayum AA, Paranjape A, Taruselli M, Haque TT, Kiwanuka KN, Elford HL, Ryan JJ (date unknown). Didox (3,4-dihydroxybenzohydroxamic acid) suppresses IgE-mediated mast cell activation through attenuation of NFκB and AP-1 transcription. Vol. 322, 41-48. Accepted, .
  • Singh NK, Alonso JA, Harris DT, Anderson SD, Ma J, Hellman LM, Rosenberg AM, Kolawole EM, Evavold BD, Kranz DM, Baker BM. (date unknown). An Engineered T Cell Receptor Variant Realizes the Limits of Functional Binding Modes. Vol. 59, 4163-4175. Accepted, .
  • Fernando J, Faber TW, Pullen NA, Falanga YT, Kolawole EM, Oskeritzian CA, Barnstein BO, Bandara G, Li G, Schwartz LB, Spiegel S, Straus DB, Conrad DH, Bunting KD, Ryan JJ (date unknown). Genotype-dependent effects of TGF-β1 on mast cell function: targeting the Stat5 pathway. Vol. 191, 4505-13. Accepted, .
  • Kolawole EM, Andargachew R, Liu B, Jacobs JR, Evavold BD (date unknown). 2D Kinetic Analysis of TCR and CD8 Coreceptor for LCMV GP33 Epitopes. Vol. 9, 2348. Accepted, .
  • Abebayehu D, Spence AJ, Qayum AA, Taruselli MT, McLeod JJ, Caslin HL, Chumanevich AP, Kolawole EM, Paranjape A, Baker B, Ndaw VS, Barnstein BO, Oskeritzian CA, Sell SA, Ryan JJ (date unknown). Lactic Acid Suppresses IL-33-Mediated Mast Cell Inflammatory Responses via Hypoxia-Inducible Factor-1α-Dependent miR-155 Suppression. Vol. 197, 2909-17. Accepted, .
  • DiToro D, Winstead CJ, Pham D, Witte S, Andargachew R, Singer JR, Wilson CG, Zindl CL, Luther RJ, Silberger DJ, Weaver BT, Kolawole EM, Martinez RJ, Turner H, Hatton RD, Moon JJ, Way SS, Evavold BD, Weaver CT (date unknown). Differential IL-2 expression defines developmental fates of follicular versus nonfollicular helper T cells. Vol. 361. Accepted, .
  • Ren HM, Kolawole EM, Ren M, Jin G, Netherby-Winslow CS, Wade Q, Shwetank, Rahman ZSM, Evavold BD, Lukacher AE (date unknown). IL-21 from high-affinity CD4 T cells drives differentiation of brain-resident CD8 T cells during persistent viral infection. Vol. 5, eabb5590. Accepted, .
  • Caslin HL, McLeod JJA, Spence AJ, Qayum AA, Kolawole EM, Taruselli MT, Paranjape A, Elford HL, Ryan JJ (date unknown). Didox (3,4-dihydroxybenzohydroxamic acid) suppresses IL-33-induced cytokine production in primary mouse mast cells. Vol. 319, 10-16. Accepted, .
  • Chow IT, Gates TJ, Papadopoulos GK, Moustakas AK, Kolawole EM, Notturno RJ, McGinty JW, Torres-Chinn N, James EA, Greenbaum C, Nepom GT, Evavold BD, Kwok WW (date unknown). Discriminative T cell recognition of cross-reactive islet-antigens is associated with HLA-DQ8 transdimer-mediated autoimmune diabetes. Vol. 5, eaaw9336. Accepted, .
  • Ndaw VS, Abebayehu D, Spence AJ, Paez PA, Kolawole EM, Taruselli MT, Caslin HL, Chumanevich AP, Paranjape A, Baker B, Barnstein BO, Haque TT, Kiwanuka KN, Oskeritzian CA, Ryan JJ (date unknown). TGF-β1 Suppresses IL-33-Induced Mast Cell Function. Vol. 199, 866-873. Accepted, .
  • Sibener LV, Fernandes RA, Kolawole EM, Carbone CB, Liu F, McAffee D, Birnbaum ME, Yang X, Su LF, Yu W, Dong S, Gee MH, Jude KM, Davis MM, Groves JT, Goddard WA 3rd, Heath JR, Evavold BD, Vale RD, Garcia KC (date unknown). Isolation of a Structural Mechanism for Uncoupling T Cell Receptor Signaling from Peptide-MHC Binding. Vol. 174, 672-687.e27. Accepted, .
  • Paez PA, Kolawole M, Taruselli MT, Ajith S, Dailey JM, Kee SA, Haque TT, Barnstein BO, McLeod JJA, Caslin HL, Kiwanuka KN, Fukuoka Y, Le QT, Schwartz LB, Straus DB, Gewirtz DA, Martin RK, Ryan JJ. (date unknown). Fluvastatin Induces Apoptosis in Primary and Transformed Mast Cells. Vol. 374, 104-112. Accepted, .
  • Abebayehu D, Spence AJ, Caslin H, Taruselli M, Haque TT, Kiwanuka KN, Kolawole EM, Chumanevich AP, Sell SA, Oskeritzian CA, Ryan J, Kee SA (date unknown). Lactic acid suppresses IgE-mediated mast cell function in vitro and in vivo. Vol. 341, 103918. Accepted, .
  • Andargachew R, Martinez RJ, Kolawole EM, Evavold BD (date unknown). CD4 T Cell Affinity Diversity Is Equally Maintained during Acute and Chronic Infection. Vol. 201, 19-30. Accepted, .
  • Faber TW, Pullen NA, Fernando JF, Kolawole EM, McLeod JJ, Taruselli M, Williams KL, Rivera KO, Barnstein BO, Conrad DH, Ryan JJ (date unknown). ADAM10 is required for SCF-induced mast cell migration. Vol. 290, 80-8. Accepted, .
  • Sanecka A, Yoshida N, Kolawole EM, Patel H, Evavold BD, Frickel EM (date unknown). T Cell Receptor-Major Histocompatibility Complex Interaction Strength Defines Trafficking and CD103+ Memory Status of CD8 T Cells in the Brain. Vol. 9, 1290. Accepted, .
  • Kiwanuka KN, Motunrayo Kolawole E, Mcleod JJA, Baker B, Paez PA, Zellner MP, Haque TT, Paranjape A, Jackson K, Kee SA, Dailey J, Martin RK, Ryan JJ (date unknown). Stat5B is required for IgE-Mediated mast cell function in vitro and in vivo. Accepted, .
  • Qayum AA, Paranjape A, Abebayehu D, Kolawole EM, Haque TT, McLeod JJ, Spence AJ, Caslin HL, Taruselli MT, Chumanevich AP, Baker B, Oskeritzian CA, Ryan JJ (date unknown). IL-10-Induced miR-155 Targets SOCS1 To Enhance IgE-Mediated Mast Cell Function. Vol. 196, 4457-67. Accepted, .
  • Dileepan T, Malhotra D, Kotov DI, Kolawole EM, Krueger PD, Evavold BD, Jenkins MK. (date unknown). MHC class II tetramers engineered for enhanced binding to CD4 improve detection of antigen-specific T cells. Accepted, .
  • Falanga YT, Chaimowitz NS, Charles N, Finkelman FD, Pullen NA, Barbour S, Dholaria K, Faber T, Kolawole M, Huang B, Odom S, Rivera J, Carlyon J, Conrad DH, Spiegel S, Oskeritzian CA, Ryan JJ (date unknown). Lyn but not Fyn kinase controls IgG-mediated systemic anaphylaxis. Vol. 188, 4360-8. Accepted, .
  • Speiran K, Bailey DP, Fernando J, Macey M, Barnstein B, Kolawole M, Curley D, Watowich SS, Murray PJ, Oskeritzian C, Ryan JJ (date unknown). Endogenous suppression of mast cell development and survival by IL-4 and IL-10. Vol. 85, 826-36. Accepted, .
  • Oskeritzian CA, Hait NC, Wedman P, Chumanevich A, Kolawole EM, Price MM, Falanga YT, Harikumar KB, Ryan JJ, Milstien S, Sabbadini R, Spiegel S (date unknown). The sphingosine-1-phosphate/sphingosine-1-phosphate receptor 2 axis regulates early airway T-cell infiltration in murine mast cell-dependent acute allergic responses. Vol. 135, 1008-18.e1. Accepted, .
  • Morales JK, Saleem SJ, Martin RK, Saunders BL, Barnstein BO, Faber TW, Pullen NA, Kolawole EM, Brooks KB, Norton SK, Sturgill J, Graham L, Bear HD, Urban JF Jr, Lantz CS, Conrad DH, Ryan JJ (date unknown). Myeloid-derived suppressor cells enhance IgE-mediated mast cell responses. Vol. 95, 643-50. Accepted, .
  • Liu B, Hood JD, Kolawole EM, Woodruff DM, Vignali DA, Bettini M, Evavold BD (date unknown). A Hybrid Insulin Epitope Maintains High 2D Affinity for Diabetogenic T Cells in the Periphery. Vol. 69, 381-391. Accepted, .
  • Bettini M, Scavuzzo MA, Liu B, Kolawole E, Guo L, Evavold BD, Borowiak M, Bettini ML (date unknown). A Critical Insulin TCR Contact Residue Selects High-Affinity and Pathogenic Insulin-Specific T Cells. Vol. 69, 392-400. Accepted, .
  • Kolawole EM, McLeod JJ, Ndaw V, Abebayehu D, Barnstein BO, Faber T, Spence AJ, Taruselli M, Paranjape A, Haque TT, Qayum AA, Kazmi QA, Wijesinghe DS, Sturgill JL, Chalfant CE, Straus DB, Oskeritzian CA, Ryan JJ (date unknown). Fluvastatin Suppresses Mast Cell and Basophil IgE Responses: Genotype-Dependent Effects. Vol. 196, 1461-70. Accepted, .
  • Moore T, Wagner CR, Scurti GM, Hutchens KA, Godellas C, Clark AL, Kolawole EM, Hellman LM, Singh NK, Huyke FA, Wang SY, Calabrese KM, Embree HD, Orentas R, Shirai K, Dellacecca E, Garrett-Mayer E, Li M, Eby JM, Stiff PJ, Evavold BD, Baker BM, Le Poole IC, Dropulic B, Clark JI, Nishimura MI (date unknown). Clinical and immunologic evaluation of three metastatic melanoma patients treated with autologous melanoma-reactive TCR-transduced T cells. Vol. 67, 311-325. Accepted, .
  • Kolawole EM, Lamb TJ, Evavold BD. (date unknown). Relationship of 2D Affinity to T Cell Functional Outcomes. Vol. 21. Accepted, .